CHICMAX (02145) Enters Strategic Collaboration Framework with Suzhou Kintor for KT-939

Stock News03-17

CHICMAX (02145) has announced that it recently signed a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kintor Pharmaceutical Limited (listed on the Hong Kong Stock Exchange, stock code: 9939). The agreement includes exclusivity clauses in the cosmetics field and pertains to the rapid commercialization of the cosmetic ingredient KT-939, which is known for its skin-whitening and spot-removing effects. Under the framework agreement, CHICMAX and Suzhou Kintor will collaborate on the registration of KT-939 as a new cosmetic ingredient in China, as well as the registration of cosmetic products using KT-939 as a core component. The partnership will also involve joint research, development, and customization of functional ingredients, with the goal of creating an industry-leading "strongest domestic whitening product" based on KT-939. CHICMAX plans to leverage the development, registration, and application of KT-939 to further diversify its product portfolio, enhance its scientific research capabilities in advanced cosmetic ingredients and product efficacy, and strengthen its leadership in the functional whitening and spot-removing cosmetics market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142595528?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 20:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142595528","market":"sh","top_or_hot":-1,"title":"CHICMAX (02145) Enters Strategic Collaboration Framework with Suzhou Kintor for KT-939","media":"Stock News","content":"<p>CHICMAX (02145) has announced that it recently signed a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kintor Pharmaceutical Limited (listed on the Hong Kong Stock Exchange, stock code: 9939). The agreement includes exclusivity clauses in the cosmetics field and pertains to the rapid commercialization of the cosmetic ingredient KT-939, which is known for its skin-whitening and spot-removing effects. Under the framework agreement, CHICMAX and Suzhou Kintor will collaborate on the registration of KT-939 as a new cosmetic ingredient in China, as well as the registration of cosmetic products using KT-939 as a core component. The partnership will also involve joint research, development, and customization of functional ingredients, with the goal of creating an industry-leading \"strongest domestic whitening product\" based on KT-939. CHICMAX plans to leverage the development, registration, and application of KT-939 to further diversify its product portfolio, enhance its scientific research capabilities in advanced cosmetic ingredients and product efficacy, and strengthen its leadership in the functional whitening and spot-removing cosmetics market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHICMAX (02145) Enters Strategic Collaboration Framework with Suzhou Kintor for KT-939</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHICMAX (02145) Enters Strategic Collaboration Framework with Suzhou Kintor for KT-939\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-17 20:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CHICMAX (02145) has announced that it recently signed a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kintor Pharmaceutical Limited (listed on the Hong Kong Stock Exchange, stock code: 9939). The agreement includes exclusivity clauses in the cosmetics field and pertains to the rapid commercialization of the cosmetic ingredient KT-939, which is known for its skin-whitening and spot-removing effects. Under the framework agreement, CHICMAX and Suzhou Kintor will collaborate on the registration of KT-939 as a new cosmetic ingredient in China, as well as the registration of cosmetic products using KT-939 as a core component. The partnership will also involve joint research, development, and customization of functional ingredients, with the goal of creating an industry-leading \"strongest domestic whitening product\" based on KT-939. CHICMAX plans to leverage the development, registration, and application of KT-939 to further diversify its product portfolio, enhance its scientific research capabilities in advanced cosmetic ingredients and product efficacy, and strengthen its leadership in the functional whitening and spot-removing cosmetics market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1207","symbol_name":"个人用品","start_time":0,"source_url":"","article_id":"1142595528","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142595528","pubTimestamp":1773749349,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CHICMAX (02145) has announced that it recently signed a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kintor Pharmaceutical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1207":"个人用品","02145":"上美股份","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","BK4115":"综合电信业务","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU0541502299.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","LU0541501648.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","KT":"韩国电信"},"translate_title":"CHICMAX(02145)与苏州开拓就KT-939订立战略合作框架","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KT":1,"02145":1},"content_text":"CHICMAX (02145) has announced that it recently signed a strategic cooperation framework agreement with Suzhou Kintor Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kintor Pharmaceutical Limited (listed on the Hong Kong Stock Exchange, stock code: 9939). The agreement includes exclusivity clauses in the cosmetics field and pertains to the rapid commercialization of the cosmetic ingredient KT-939, which is known for its skin-whitening and spot-removing effects. Under the framework agreement, CHICMAX and Suzhou Kintor will collaborate on the registration of KT-939 as a new cosmetic ingredient in China, as well as the registration of cosmetic products using KT-939 as a core component. The partnership will also involve joint research, development, and customization of functional ingredients, with the goal of creating an industry-leading \"strongest domestic whitening product\" based on KT-939. CHICMAX plans to leverage the development, registration, and application of KT-939 to further diversify its product portfolio, enhance its scientific research capabilities in advanced cosmetic ingredients and product efficacy, and strengthen its leadership in the functional whitening and spot-removing cosmetics market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142595528","isCrawlerRequest":true}